Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okudaira, Y.
Right arrow Articles by Sato, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okudaira, Y.
Right arrow Articles by Sato, K.

(Stroke. 1996;27:617-621.)
© 1996 American Heart Association, Inc.


Articles

Cerebral Blood Flow Alteration by Acetazolamide During Carotid Balloon Occlusion

Parameters Reflecting Cerebral Perfusion Pressure in the Acetazolamide Test

Yojiro Okudaira, MD; Hajime Arai, MD Kiyoshi Sato, MD

From the Department of Neurosurgery, Juntendo University, Tokyo, Japan.

Background and Purpose We attempted to clarify the role of the acetazolamide-reactive mechanism in cerebral hemodynamic autoregulation and to establish a useful method of estimation using the acetazolamide test.

Methods We examined 18 patients whose cerebral hemodynamics were considered to be normal and whose cerebral blood flow (CBF) was maintained during the balloon occlusion test (BOT) of the internal carotid artery. We measured the mean stump pressure (MSTP) and the mean CBF in the middle cerebral arterial territory using a xenon-enhanced CT system during BOT with and without acetazolamide activation. We obtained the asymmetry ratio (AR=occluded CBF/contralateral CBF) and the increased CBF parameters caused by acetazolamide activation expressed as an absolute value ({Delta}CBF) and a percentage (%{Delta}CBF) for the occluded side.

Results AR during BOT with and without acetazolamide activation differed significantly (P<.001, paired t test) despite the lack of significant MSTP changes. Furthermore, although there was no significant correlation between MSTP and AR without acetazolamide activation, a positive significant correlation was detected with acetazolamide activation (r=.634, P=.005, linear regression analysis). There were significant correlations between {Delta}CBF and MSTP (r=.574, P=.013) and %{Delta}CBF and MSTP (r=.640, P=.004).

Conclusions We consider that the acetazolamide-reactive mechanism functions as autoregulation at the lower end of the autoregulatory range. The acetazolamide test, using %{Delta}CBF or {Delta}CBF as parameters (which both directly reflect MSTP), is useful for estimating the cerebral perfusion pressure decrease and presence of hemodynamic compromise.


Key Words: acetazolamide • autoregulation • carotid arteries • cerebral blood flow • xenon




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
I. Uzunca, T. Asil, K. Balci, and U. Utku
Evaluation of Vasomotor Reactivity by Transcranial Doppler Sonography in Patients With Acute Stroke Who Have Symptomatic Intracranial and Extracranial Stenosis
J. Ultrasound Med., February 1, 2007; 26(2): 179 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N. Tomura, K. Omachi, S. Takahashi, I. Sakuma, T. Otani, J. Watarai, K. Ishikawa, H. Kinouchi, and K. Mizoi
Comparison of Technetium Tc 99m Hexamethylpropyleneamine Oxime Single-Photon Emission Tomograph with Stump Pressure During the Balloon Occlusion Test of the Internal Carotid Artery
AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 1937 - 1942.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. G. Hoeffner, I. Case, R. Jain, S. K. Gujar, G. V. Shah, J. P. Deveikis, R. C. Carlos, B. G. Thompson, M. R. Harrigan, and S. K. Mukherji
Cerebral Perfusion CT: Technique and Clinical Applications
Radiology, June 1, 2004; 231(3): 632 - 644.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. Jain, E. G. Hoeffner, J. P. Deveikis, M. R. Harrigan, B. G. Thompson, and S. K. Mukherji
Carotid Perfusion CT with Balloon Occlusion and Acetazolamide Challenge Test: Feasibility
Radiology, June 1, 2004; 231(3): 906 - 913.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Demolis, G. Florence, L. Thomas, Y. R. Tran Dinh, J.-F. Giudicelli, J. Seylaz, and N. J. Alkayed
Is the Acetazolamide Test Valid for Quantitative Assessment of Maximal Cerebral Autoregulatory Vasodilation? : An Experimental Study • Editorial Comment: An Experimental Study
Stroke, February 1, 2000; 31(2): 508 - 515.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Kaminogo, M. Ochi, M. Onizuka, H. Takahata, and S. Shibata
An Additional Monitoring of Regional Cerebral Oxygen Saturation to HMPAO SPECT Study During Balloon Test Occlusion
Stroke, February 1, 1999; 30(2): 407 - 413.
[Abstract] [Full Text] [PDF]